CGON - CIK 0001991792
The table below shows CG Oncology, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $33.70M | $45.15M | $14.62M | $41.47M | $43.41M | $25.16M |
| Short-term investments | $1.04B | $635.12M | $646.43M | $646.96M | $497.30M | $527.72M |
| Receivables | - | - | - | - | - | - |
| Inventory | $1.49M | $1.50M | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.10B |
| $695.79M |
| $673.03M |
| $701.19M |
| $552.08M |
| $563.86M |
| Property, plant & equipment | $15.07M | $15.33M | $253.00K | $264.00K | $63.00K | $84.00K |
| Goodwill | $10.30M | $12.80M | - | - | - | - |
| Total assets | $1.14B | $729.91M | $701.45M | $728.18M | $552.47M | $564.33M |
| Accounts payable | $8.24M | $9.19M | $7.13M | $6.73M | $4.08M | $4.49M |
| Total current liabilities | $35.22M | $30.53M | $30.38M | $22.64M | $15.63M | $11.85M |
| Long-term debt | $3.00M | $3.00M | - | - | - | - |
| Total liabilities | $43.48M | $42.27M | $31.09M | $23.42M | $15.70M | $11.97M |
| Retained earnings | -$439.18M | -$337.67M | -$293.86M | -$252.43M | -$186.18M | -$165.78M |
| Total equity | $1.09B | $687.64M | $670.36M | $704.76M | $536.77M | $552.36M |